DYNAMIC INTERACTIONS OF BIOFILMS OF MUCOID PSEUDOMONAS-AERUGINOSA WITH TOBRAMYCIN AND PIPERACILLIN

被引:97
作者
ANWAR, H [1 ]
STRAP, JL [1 ]
CHEN, K [1 ]
COSTERTON, JW [1 ]
机构
[1] UNIV CALGARY,DEPT BIOL SCI,CALGARY T2N 1N4,ALBERTA,CANADA
关键词
D O I
10.1128/AAC.36.6.1208
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The dynamic interaction of planktonic and biofilm cells of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin was investigated in a chemostat system. The results indicated that planktonic and young biofilm cells of the 2-day-old chemostat culture of P. aeruginosa were susceptible to killing by chemostat-controlled doses of either 250-mu-g of piperacillin per ml plus 5-mu-g of tobramycin per ml or 500-mu-g of piperacillin per ml plus 5-mu-g of tobramycin per ml. Complete eradication of the planktonic and young biofilm cells was observed after exposure of the cells to six chemostat-controlled doses of these antibiotics at 8-h intervals for 7 days. Regrowth of the organism was not observed after the termination of antibiotic therapy on day 7. A different picture was observed when antibiotic treatment was initiated on day 10 after inoculation. Viable old biofilm cells were reduced to approximately 20% after exposure to the chemostat-controlled doses of 500-mu-g of piperacillin per ml plus 5-mu-g of tobramycin per ml. Complete eradication of old biofilm cells could not be achieved, and regrowth of the organism occurred after the termination of antibiotic therapy. These data suggest that young biofilm cells of mucoid P. aeruginosa can be effectively eradicated with the combination of piperacillin and tobramycin, while old biofilm cells are very resistant to these antibiotics and eradication of old biofilm cells is not achievable with the chemostat-controlled doses of piperacillin and tobramycin used in this study.
引用
收藏
页码:1208 / 1214
页数:7
相关论文
共 30 条
  • [21] ALGINATE SYNTHESIS BY PSEUDOMONAS-AERUGINOSA - A KEY PATHOGENIC FACTOR IN CHRONIC PULMONARY INFECTIONS OF CYSTIC-FIBROSIS PATIENTS
    MAY, TB
    SHINABARGER, D
    MAHARAJ, R
    KATO, J
    CHU, L
    DEVAULT, JD
    ROYCHOUDHURY, S
    ZIELINSKI, NA
    BERRY, A
    ROTHMEL, RK
    MISRA, TK
    CHAKRABARTY, AM
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1991, 4 (02) : 191 - 206
  • [22] THE CONTRIBUTION OF EXOPRODUCTS TO VIRULENCE OF PSEUDOMONAS-AERUGINOSA
    NICAS, TI
    IGLEWSKI, BH
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1985, 31 (04) : 387 - 392
  • [23] NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291
  • [24] TOBRAMYCIN RESISTANCE OF PSEUDOMONAS-AERUGINOSA CELLS GROWING AS A BIOFILM ON URINARY CATHETER MATERIAL
    NICKEL, JC
    RUSESKA, I
    WRIGHT, JB
    COSTERTON, JW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) : 619 - 624
  • [25] PULMONARY-DISEASE ASSOCIATED WITH PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS - CURRENT STATUS OF THE HOST-BACTERIUM INTERACTION
    PIER, GB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) : 575 - 580
  • [26] PLATT TB, 1986, MODERN ANAL ANTIBIOT, V27, P341
  • [27] SANDERS CC, 1991, ASM NEWS, V57, P187
  • [28] ANTIBIOTIC PENETRATION THROUGH BACTERIAL CAPSULES AND EXOPOLYSACCHARIDES
    SLACK, MPE
    NICHOLS, WW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (05) : 368 - 372
  • [29] INFLUENCE OF INTERFACES ON MICROBIAL ACTIVITY
    VANLOOSDRECHT, MCM
    LYKLEMA, J
    NORDE, W
    ZEHNDER, AJB
    [J]. MICROBIOLOGICAL REVIEWS, 1990, 54 (01) : 75 - 87
  • [30] PSEUDOMONAS-AERUGINOSA - BIOLOGY, MECHANISMS OF VIRULENCE, EPIDEMIOLOGY
    VASIL, ML
    [J]. JOURNAL OF PEDIATRICS, 1986, 108 (05) : 800 - 805